Cesar J. M.
- Country
- Spain
- Department
- Cardiology
Research Overview
Data & Insights
Has run more than one trial at 0 of 4 partner sites.
Specializations
Cardiovascular Therapeutics
The investigator concentrates on preventing cardiac dysfunction in at‑risk populations and optimizing post‑procedural antithrombotic strategies. Emphasis is placed on dilated cardiomyopathy genetics and acute coronary syndromes.
- Early intervention in dilated cardiomyopathy genetic carriers
- Management of spontaneous coronary artery dissection
- Secondary prevention using colchicine in chronic kidney disease patients
- Optimization of antiplatelet therapy after transcatheter aortic valve implantation
Collaborative work integrates advanced imaging and biomarker profiling to refine risk stratification.
Metabolic & Lipid Disorders
Research targets dyslipidaemia and obesity linked to genetic and lifestyle factors, seeking novel agents to modify serum triglycerides and body weight. The focus includes severe hypertriglyceridemia and familial cholesterol abnormalities.
- Therapeutic reduction of hypertriglyceridemia
- Weight management with setmelanotide in genetic obesity
- Impact of simvastatin on recurrent pancreatitis risk
- Addressing heterozygous familial hypercholesterolemia
Outcomes assess metabolic parameters and long‑term cardiovascular risk.
Oncology & Cancer Therapeutics
The investigator’s oncology portfolio spans solid tumours with an emphasis on targeted and immuno‑oncologic approaches. Key interest areas include HER2‑positive breast cancer and high‑risk bladder neoplasms.
- Targeted therapy for HER2‑positive breast cancer
- Management of high‑risk non‑muscle invasive bladder cancer
- Combination immunotherapy in triple‑negative breast cancer
- Treatment strategies for RET‑fusion positive NSCLC
Clinical programs evaluate survival endpoints and molecular response markers.
Pulmonary Fibrosis & Respiratory Diseases
Focused on progressive fibrotic lung conditions, the work investigates antifibrotic agents and novel biologics to preserve lung capacity. Primary conditions studied are idiopathic pulmonary fibrosis and related progressive forms.
- Antifibrotic therapy for idiopathic pulmonary fibrosis
- Evaluation of novel agents in progressive pulmonary fibrosis
- Lung function outcomes with axatilimab
- Clinical impact of inhaled pirfenidone
Studies incorporate functional imaging and quality‑of‑life assessments.
Dermatology & Autoimmune Skin Disorders
Investigation in inflammatory skin diseases emphasizes biologic and small‑molecule interventions for chronic conditions such as hidradenitis suppurativa and urticaria.
- Biologic treatment for hidradenitis suppurativa
- Management of chronic spontaneous urticaria
- Emerging therapies for atopic dermatitis
- Clinical trials targeting vitiligo
Endpoints include disease activity scores and patient‑reported outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.